Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Inv. presentation

HERON THERAPEUTICS, INC. (HRTX) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/24/2023 4 Collard Craig A (CEO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/
Txns: Paid exercise price by delivering 692 shares @ $1.65, valued at $1.1k
07/25/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/25/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
07/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/17/2023 4 Szekeres David Leslie (EVP, COO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/
Txns: Paid exercise price by delivering 2,012 shares @ $1.31, valued at $2.6k
Exercised 1,250 restricted stock units @ $0
Exercised 4,564 restricted stock units @ $0
07/17/2023 4 Peraza Lisa (VP, Chief Accounting Officer) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/
Txns: Paid exercise price by delivering 860 shares @ $1.31, valued at $1.1k
Exercised 552 restricted stock units @ $0
Exercised 1,933 restricted stock units @ $0
06/12/2023 3 Forbes William P (EVP, Chief Development Officer) has filed a Form 3 on HERON THERAPEUTICS, INC. /DE/
05/24/2023 4 Collard Craig A (CEO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/
Txns: Paid exercise price by delivering 691 shares @ $1.45, valued at $1k
04/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/05/2023 4 Collard Craig A (CEO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/
Txns: Granted 3,000,000 options to buy @ $1.78, valued at $5.3M
Granted 250,000 restricted stock units @ $0
Granted 4,250,000 options to buy @ $1.78, valued at $7.6M
03/02/2023 3 KOTLER KEVIN (Director) has filed a Form 3 on HERON THERAPEUTICS, INC. /DE/
03/02/2023 3 Collard Craig A (Director) has filed a Form 3 on HERON THERAPEUTICS, INC. /DE/
02/24/2023 4 Morgan Adam (Director) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/
Txns: Granted 37,879 shares @ $0
Granted 227,272 options to buy @ $2.7, valued at $613.6k
02/08/2023 3 Velan Capital Investment Management LP (See Footnote 2) has filed a Form 3 on HERON THERAPEUTICS, INC. /DE/
02/08/2023 3 Rubric Capital Management LP (See Footnote 1) has filed a Form 3 on HERON THERAPEUTICS, INC. /DE/
01/20/2023 4 Szekeres David Leslie (EVP, COO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/
Txns: Granted 49,788 rights @ $0
01/20/2023 4 Quart Barry D (CEO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/
Txns: Granted 850,000 options to buy @ $3.13, valued at $2.7M
01/20/2023 4 POYHONEN JOHN (President & CCO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/
Txns: Granted 66,385 rights @ $0
01/20/2023 4 Peraza Lisa (VP, Chief Accounting Officer) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/
Txns: Granted 42,631 rights @ $0
01/20/2023 4 MANHARD KIMBERLY (EVP, Drug Development) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/
Txns: Granted 149,365 rights @ $0
01/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/20/2022 4 Christian Waage (Director) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/
Txns: Granted 38,580 shares @ $0
Granted 77,160 options to buy @ $2.74, valued at $211.4k
12/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/20/2022 4 Johnson Craig A (Director) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/
Txns: Granted 38,580 shares @ $0
Granted 77,160 options to buy @ $2.74, valued at $211.4k
12/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/20/2022 4 DAVIS STEPHEN (Director) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/
Txns: Granted 38,580 shares @ $0
Granted 77,160 options to buy @ $2.74, valued at $211.4k
10/17/2022 4 Szekeres David Leslie (EVP, COO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/
Txns: Paid exercise price by delivering 2,012 shares @ $3.76, valued at $7.6k
Exercised 1,250 restricted stock units @ $0
Exercised 4,564 restricted stock units @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy